Skip to main content

New Aspirin Guide Mobile app helping clinicians and patients... both

New Aspirin-Guide mobile app helps clinicians and patients make informed decisions about aspirin use

Posted in: Device / Technology News | Medical Research News | Medical Condition News | Pharmaceutical News

Published on June 21, 2016 at 12:15 PM

Low dose aspirin is recommended by clinicians as a preventive measure for patients who have already had a heart attack or stroke, but the risk of taking low-dose aspirin to prevent or delay a first heart attack or stroke is less clear, as the benefit for reducing the risk of cardiovascular disease (CVD) must be balanced with the increased risk of gastrointestinal or other bleeding. To help clinicians and patients make informed decisions about aspirin use, researchers at Brigham and Women's Hospital have developed a new, free, mobile app, "Aspirin-Guide" that calculates both the CVD risk score and the bleeding risk score for the individual patient, and helps clinicians decide which patients are appropriate candidates for the use of low-dose aspirin (75 to 81 mg daily).

"We developed the Aspirin-Guide app because we realized that weighing the risks and benefits of aspirin for individuals who have not had a heart attack or stroke is a complex process. The new mobile app enables individualized benefit to risk assessment in a matter of seconds while the patient is with the physician," said Samia Mora, MD, cardiologist at BWH.

In a commentary published in JAMA in the June 20 issue, and a review in JAMA Internal Medicine published on the same day, co-authors Mora, and JoAnn Manson, MD, cardiovascular epidemiologist and Chief of Preventive Medicine at BWH, review the evidence behind the use of aspirin to delay or prevent a first heart attack of stroke, and give examples of how the mobile app can help patients and clinicians including:

•calculates a 10-year cardiovascular disease risk score (heart disease and stroke) for the patient
•calculates a bleeding risk score based on the patient's individual risk factors
•uses evidence from the literature, together with the above scores, to compare the number needed to treat vs. the number needed to harm
•helps clinicians to implement current clinical guidelines for low-dose aspirin in primary prevention
•provides the ability to email a summary of the decision-making process to the patient and/or to the clinician for the patient's record.

"Aspirin-Guide is a user-friendly clinical decision support tool, that will facilitate informed and personalized decision-making about the use of aspirin in primary prevention of CVD. Patients should discuss the pros and cons of aspirin treatment with their healthcare provider," Manson said.

Source: Brigham and Women’s Hospital

Comments

Post a Comment

Popular posts from this blog

Exercise and proper sleep can reduce cancer risk

The latest research shows that proper exercise which should be regulated ( Like 30mins daily ) and proper sleep can reduce cancer risks. Because, daily exercise maintains body metabolism in a steady way and this prevents altered metabolism within our body. Also, proper sleep which should be at least 6 hours at night can reduces the altered endocrine and metabolic functions. So, proper sleep is very important. This all can reduce cancer risks upto 55%.
Post a Comment
Read more

Treatment with stem cells, a new era in medical science.......

A new Era is coming forward in the treatment of human body. That is the STEM CELL THERAPY. If this treatment comes forward then medical science can treat many of those major diseases that are killing a large number of people each year. There are many diseases now that can't be cured by medical treatment, like Paralysis . If a patient has paralysis then doctors give him only some supportive treatment to improve his nerve supply on that affected area. But it can't give a redical cure. Because if a nerve cell damaged it cant be regenerated due to it is mane if stable cells. But, if a stem cell is replaced on that area then it can regenerate a nerve cell because stem cell can grow in the form of any cells or tissues, it has that capacity. Although a stem cell can grow in any form of a tissue or an organ. So, if we can place a stem cell in that affected hand or leg then this stem cell will grow under control and can regenerate into that original tissue. So, the patient will be cu...
Post a Comment
Read more

Artificial pancreas ... an option

Coming Soon: 'Artificial Pancreas' Options for Diabetes Miriam E Tucker June 20, 2016   NEW ORLEANS — Nearly closed-loop systems (also referred to as an "artificial pancreas") for improving glycemic control and minimizing hypoglycemia in type 1 diabetes are advancing rapidly, including iterations that deliver insulin alone, insulin with glucagon, or glucagon alone. Findings for several of the products in development demonstrating improvements in glycemic control and reductions in hypoglycemia were presented here at the  American Diabetes Association (ADA) 2016 Scientific Sessions . "Some people may do well on insulin only, while others may need glucagon," Vincent Crabtree, PhD, director of the artificial pancreas program at JDRF, in New York, told  Medscape Medical News , adding, "JDRF would like people to have choice, and we'd like all to be covered [by payers]." The insulin-only hybrid closed-loop 670G system (Medtronic MiniMed) is the...
Post a Comment
Read more